The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Enzyme Replacement Therapy-Global Market Insights and Sales Trends 2025

Enzyme Replacement Therapy-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1817140

No of Pages : 102

Synopsis
Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
The global Enzyme Replacement Therapy market size is expected to reach US$ 29910 million by 2029, growing at a CAGR of 14.0% from 2023 to 2029. The market is mainly driven by the significant applications of Enzyme Replacement Therapy in various end use industries. The expanding demands from the Gaucher Disease, Fabry Disease, MPS Disease and Gastrointestinal Disease, are propelling Enzyme Replacement Therapy market. Injectable Agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Agents segment is estimated at % CAGR for the next seven-year period.
Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.
In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enzyme Replacement Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enzyme Replacement Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enzyme Replacement Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enzyme Replacement Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enzyme Replacement Therapy covered in this report include Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson and Actelion, etc.
The global Enzyme Replacement Therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences
Global Enzyme Replacement Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enzyme Replacement Therapy market, Segment by Type:
Injectable Agents
Oral Agents
Global Enzyme Replacement Therapy market, by Application
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enzyme Replacement Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enzyme Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Enzyme Replacement Therapy Market Overview
1.1 Enzyme Replacement Therapy Product Overview
1.2 Enzyme Replacement Therapy Market Segment by Type
1.2.1 Injectable Agents
1.2.2 Oral Agents
1.3 Global Enzyme Replacement Therapy Market Size by Type
1.3.1 Global Enzyme Replacement Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Enzyme Replacement Therapy Historic Market Size Review by Type (2018-2023)
1.3.3 Global Enzyme Replacement Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Enzyme Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.2 Europe Enzyme Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Enzyme Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Enzyme Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Enzyme Replacement Therapy Sales Breakdown by Type (2018-2023)
2 Global Enzyme Replacement Therapy Market Competition by Company
2.1 Global Top Players by Enzyme Replacement Therapy Sales (2018-2023)
2.2 Global Top Players by Enzyme Replacement Therapy Revenue (2018-2023)
2.3 Global Top Players by Enzyme Replacement Therapy Price (2018-2023)
2.4 Global Top Manufacturers Enzyme Replacement Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Enzyme Replacement Therapy Market Competitive Situation and Trends
2.5.1 Enzyme Replacement Therapy Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Enzyme Replacement Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enzyme Replacement Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Enzyme Replacement Therapy Market
2.8 Key Manufacturers Enzyme Replacement Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Enzyme Replacement Therapy Status and Outlook by Region
3.1 Global Enzyme Replacement Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Enzyme Replacement Therapy Historic Market Size by Region
3.2.1 Global Enzyme Replacement Therapy Sales in Volume by Region (2018-2023)
3.2.2 Global Enzyme Replacement Therapy Sales in Value by Region (2018-2023)
3.2.3 Global Enzyme Replacement Therapy Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Enzyme Replacement Therapy Forecasted Market Size by Region
3.3.1 Global Enzyme Replacement Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Enzyme Replacement Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Enzyme Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Enzyme Replacement Therapy by Application
4.1 Enzyme Replacement Therapy Market Segment by Application
4.1.1 Gaucher Disease
4.1.2 Fabry Disease
4.1.3 MPS Disease
4.1.4 Gastrointestinal Disease
4.1.5 Others
4.2 Global Enzyme Replacement Therapy Market Size by Application
4.2.1 Global Enzyme Replacement Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Enzyme Replacement Therapy Historic Market Size Review by Application (2018-2023)
4.2.3 Global Enzyme Replacement Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Enzyme Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.2 Europe Enzyme Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Enzyme Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Enzyme Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Enzyme Replacement Therapy Sales Breakdown by Application (2018-2023)
5 North America Enzyme Replacement Therapy by Country
5.1 North America Enzyme Replacement Therapy Historic Market Size by Country
5.1.1 North America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Enzyme Replacement Therapy Sales in Volume by Country (2018-2023)
5.1.3 North America Enzyme Replacement Therapy Sales in Value by Country (2018-2023)
5.2 North America Enzyme Replacement Therapy Forecasted Market Size by Country
5.2.1 North America Enzyme Replacement Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Enzyme Replacement Therapy Sales in Value by Country (2024-2029)
6 Europe Enzyme Replacement Therapy by Country
6.1 Europe Enzyme Replacement Therapy Historic Market Size by Country
6.1.1 Europe Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Enzyme Replacement Therapy Sales in Volume by Country (2018-2023)
6.1.3 Europe Enzyme Replacement Therapy Sales in Value by Country (2018-2023)
6.2 Europe Enzyme Replacement Therapy Forecasted Market Size by Country
6.2.1 Europe Enzyme Replacement Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Enzyme Replacement Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Enzyme Replacement Therapy by Region
7.1 Asia-Pacific Enzyme Replacement Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Enzyme Replacement Therapy Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Enzyme Replacement Therapy Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Enzyme Replacement Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Enzyme Replacement Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Enzyme Replacement Therapy Sales in Value by Region (2024-2029)
8 Latin America Enzyme Replacement Therapy by Country
8.1 Latin America Enzyme Replacement Therapy Historic Market Size by Country
8.1.1 Latin America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Enzyme Replacement Therapy Sales in Volume by Country (2018-2023)
8.1.3 Latin America Enzyme Replacement Therapy Sales in Value by Country (2018-2023)
8.2 Latin America Enzyme Replacement Therapy Forecasted Market Size by Country
8.2.1 Latin America Enzyme Replacement Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Enzyme Replacement Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Enzyme Replacement Therapy by Country
9.1 Middle East and Africa Enzyme Replacement Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Enzyme Replacement Therapy Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Enzyme Replacement Therapy Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Enzyme Replacement Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Enzyme Replacement Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Enzyme Replacement Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Enzyme Replacement Therapy Products Offered
10.1.5 Sanofi Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Takeda Enzyme Replacement Therapy Products Offered
10.2.5 Takeda Recent Development
10.3 BioMarin
10.3.1 BioMarin Company Information
10.3.2 BioMarin Introduction and Business Overview
10.3.3 BioMarin Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BioMarin Enzyme Replacement Therapy Products Offered
10.3.5 BioMarin Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Information
10.4.2 AbbVie Introduction and Business Overview
10.4.3 AbbVie Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AbbVie Enzyme Replacement Therapy Products Offered
10.4.5 AbbVie Recent Development
10.5 Alexion
10.5.1 Alexion Company Information
10.5.2 Alexion Introduction and Business Overview
10.5.3 Alexion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Alexion Enzyme Replacement Therapy Products Offered
10.5.5 Alexion Recent Development
10.6 Allergan
10.6.1 Allergan Company Information
10.6.2 Allergan Introduction and Business Overview
10.6.3 Allergan Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Allergan Enzyme Replacement Therapy Products Offered
10.6.5 Allergan Recent Development
10.7 Horizon Pharma
10.7.1 Horizon Pharma Company Information
10.7.2 Horizon Pharma Introduction and Business Overview
10.7.3 Horizon Pharma Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Horizon Pharma Enzyme Replacement Therapy Products Offered
10.7.5 Horizon Pharma Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Enzyme Replacement Therapy Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Actelion
10.9.1 Actelion Company Information
10.9.2 Actelion Introduction and Business Overview
10.9.3 Actelion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Actelion Enzyme Replacement Therapy Products Offered
10.9.5 Actelion Recent Development
10.10 Recordati Rare Diseases
10.10.1 Recordati Rare Diseases Company Information
10.10.2 Recordati Rare Diseases Introduction and Business Overview
10.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Recordati Rare Diseases Enzyme Replacement Therapy Products Offered
10.10.5 Recordati Rare Diseases Recent Development
10.11 Pfizer
10.11.1 Pfizer Company Information
10.11.2 Pfizer Introduction and Business Overview
10.11.3 Pfizer Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Pfizer Enzyme Replacement Therapy Products Offered
10.11.5 Pfizer Recent Development
10.12 Digestive Care
10.12.1 Digestive Care Company Information
10.12.2 Digestive Care Introduction and Business Overview
10.12.3 Digestive Care Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Digestive Care Enzyme Replacement Therapy Products Offered
10.12.5 Digestive Care Recent Development
10.13 Leadiant Biosciences
10.13.1 Leadiant Biosciences Company Information
10.13.2 Leadiant Biosciences Introduction and Business Overview
10.13.3 Leadiant Biosciences Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Leadiant Biosciences Enzyme Replacement Therapy Products Offered
10.13.5 Leadiant Biosciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Enzyme Replacement Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Enzyme Replacement Therapy Industrial Chain Analysis
11.4 Enzyme Replacement Therapy Market Dynamics
11.4.1 Enzyme Replacement Therapy Industry Trends
11.4.2 Enzyme Replacement Therapy Market Drivers
11.4.3 Enzyme Replacement Therapy Market Challenges
11.4.4 Enzyme Replacement Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Enzyme Replacement Therapy Distributors
12.3 Enzyme Replacement Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’